The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World by Peter Loftus
Moderna started out as a brash biotech, trying to find uses for a novel mRNA technology. The company was able to raise significant amounts of funding, but did have a bad IPO. It also had a reputation for working employees very hard. When the COVID-19 pandemic came about, they were ready to quickly develop a vaccine. Then they came to the challenges of running a big clinical trial and produce large quantities. With the government assistance, they they were able to go through the process must faster than normal. The vaccine was a success (though Pfizer beat them to market with a similar mRNA vaccine.) The vaccine worked and mRNA seemed to be better than "old" vaccine technology. Will this be the future of vaccine development?
No comments:
Post a Comment